|ndma cancer lawsuit||0.92||0.3||2091||72|
The International Agency for Research on Cancer (IARC) classifies NDMA as a group 2A carcinogen. This means it’s “probably carcinogenic to humans,” and there is sufficient evidence that it causes cancer in humans. Starting in 2018, the U.S. Food and Drug Administration released a series of warnings about several medications contaminated with NDMA.What drugs have been recalled for NDMA?
Recalled drugs include valsartan and other blood pressure drugs in the ARB class, Zantac (ranitidine) and metformin. Normally, people are exposed to small amounts of NDMA in the environment and through food and water.Is Zantac made with famotidine contaminated with NDMA?
Zantac made with famotidine is not a part of this litigation. This isn’t the first time manufacturers found NDMA contamination in drugs. In 2018, contamination led to valsartan recalls and lawsuits. But unlike valsartan, which was contaminated with NDMA during manufacturing, Zantac lawsuits claim ranitidine actually forms NDMA in the body.How many MDL Zantac cancer lawsuits have been filed?
The total number of filed MDL Zantac cancer lawsuits as of August 13, 2021, is 716. But over 70,000 census forms have been filled out at last count and that number is likely higher now.